PROCEPT BioRobotics (PRCT) Accounts Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Accounts Payables data on file, last reported at $18.9 million in Q1 2026.

• On a quarterly basis, Accounts Payables rose 27.14% year-over-year to $18.9 million in Q1 2026; TTM through Mar 2026 was $18.9 million, a 27.14% increase from a year earlier, with the FY2025 full-year figure at $17.3 million, up 72.3% from the prior year.
• Accounts Payables for Q1 2026 stood at $18.9 million, up from $17.3 million in the prior quarter.
• Over the last five years, Accounts Payables for PRCT reached as high as $18.9 million in Q1 2026 and fell as low as $2.6 million in Q1 2022.
• Historically, Accounts Payables has averaged $11.1 million across 5 years, with a median of $10.3 million in 2023.
• Across the five-year window, Accounts Payables jumped 362.84% in 2022 and decreased 26.31% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $9.4 million in 2022, then surged by 43.74% to $13.5 million in 2023, then dropped by 25.68% to $10.0 million in 2024, then surged by 72.3% to $17.3 million in 2025, then climbed by 9.06% to $18.9 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $18.9 million in Q1 2026, $17.3 million in Q4 2025, and $11.1 million in Q3 2025.